Biogen Inc. buy Royal Bank of Canada
Start price
05.06.24
/
50%
€215.30
Target price
05.06.25
€291.64
Performance (%)
-13.98%
Price
30.08.24
€185.20
Summary
This prediction is currently active. The prediction for Biogen Inc. disappoints with a performance of -13.98%. This prediction currently runs until 05.06.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | 1.119% | 1.119% |
iShares Core DAX® | 1.560% | 2.566% |
iShares Nasdaq 100 | 0.517% | 1.894% |
iShares Nikkei 225® | 1.730% | 5.631% |
iShares S&P 500 | 1.482% | 1.594% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $317.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat